Global Influenza Drugs and Vaccines Market Opportunities and Forecast 2016-2021 - Analysis by Drugs, by Vaccine, by Country and by Region
Latest Research Report titled "Global Influenza Drugs and Vaccines Market 2016-2021" features Key Market Players, Market Challenges, Market Drivers and Market Trends.
Albany, NY -- (SBWire) -- 05/30/2017 --A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Influenza Market on the basis of Segment Type (Vaccine and Drugs), By Vaccine (Trivalent and Quadrivalent), By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan).
Rising awareness in relation to influenza virus, surging investment by companies in R&D and increasing number of immunization programmes organized by the government have been some of the factors backing the growth of Global Influenza Market.
According to Azoth Analytics research report, "Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)", global market is projected to display a steady growth rate represented by a CAGR of 10.24% during 2017 – 2022, chiefly driven by increasing spending over various immunization programmes.
Get a Sample Research PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1107692
The report titled "Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)", has covered and analysed the potential of Global Influenza Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global influenza market. Additionally, the report also highlights key development and new drugs launched by various companies across the globe.
Scope of the Report
Global Influenza Market
- (Actual Period: 2012-2016E, Forecast Period: 2017-2022)
- By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
- By Vaccine Type: Trivalent, Quadrivalent
- By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir
Regional Markets – North America, Europe, APAC, RoW
- (Actual Period: 2012-2016E, Forecast Period: 2017-2022)
- By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
- By Vaccine Type: Trivalent, Quadrivalent
- By Drug Type: Zanamivi, Oseltamivir Phosphate, Peramivir
Country Analysis - US, Canada, UK, Germany, France, Japan, China, India
- (Actual Period: 2012-2016E, Forecast Period: 2017-2022)
- By Segment Type: Influenza Vaccine Market, Influenza Drugs Market
Other Report Highlights
- Market Dynamics – Trends, Drivers, Challenges
- Pipeline Analysis
- Company Analysis - Falvogen, Gilead Science and Bio Cryst
Browse Report details at: http://www.researchmoz.us/Global-Influenza-Drugs-and-Vaccines-Market-report.html
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Media Relations Contact
Mr. Nachiket
Manager
Researchmoz Global Pvt. Ltd.
518-621-2074
http://www.researchmoz.us/
View this press release online at: http://rwire.com/813490